๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Dose-response Trial of Lactoferrin in Patients with Chronic Hepatitis C

โœ Scribed by Okada, Shuichi ;Tanaka, Katsuaki ;Sato, Tosiya ;Ueno, Hideki ;Saito, Satoru ;Okusaka, Takuji ;Sato, Keiko ;Yamamoto, Seiichiro ;Kakizoe, Tadao

Book ID
108582186
Publisher
Wiley (Blackwell Publishing)
Year
2002
Tongue
English
Weight
73 KB
Volume
93
Category
Article
ISSN
0910-5050

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Response to higher doses of interferon a
Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: A randomized multicenter trial
โœ K L Lindsay; G L Davis; E R Schiff; H C Bodenheimer; L A Balart; J L Dienstag; R ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 193 KB ๐Ÿ‘ 2 views

JANICE ALBRECHT, 12 AND THE HEPATITIS INTERVENTIONAL THERAPY GROUP\* with continued therapy at that dose; however, a propor-To evaluate response rates to 3, 5, or 10 million units tion of patients who do not respond to 12 weeks of treat-(MU) of interferon alfa-2b, given thrice weekly, and to ment wi

A phase II dose-escalating trial of clev
A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B
โœ Patrick Marcellin; Herve Mommeja-Marin; Stephen L. Sacks; George K. K. Lau; Dani ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 157 KB ๐Ÿ‘ 1 views

Current therapies available for the treatment of chronic hepatitis B are limited in their ability to result in a cure. Clevudine is a new pyrimidine analog with potent anti-hepatitis B virus (HBV) activity in vitro. A multicenter dose-escalation study evaluated clevudine at 10, 50, 100, and 200 mg o